CannTrust Holdings

CannTrust Holdings, Inc. engages in the production and distribution of medical cannabis. It focuses on developing nanotechnology to create new products in the medical, recreational, beauty, wellness, and pet markets. The company was founded by Norman Paul and Eric Paul on March 16, 2015 and is headquartered in Vaughan, Canada.

HEXO Corp

Tilray Brands

Pessimism is peaking for these three popular marijuana growers.

3 Pot Stocks Short-Sellers Are Targeting

Health Canada issues a non-compliance report on CannTrust (CTST) regarding its greenhouse facility in Pelham, Ontario, which is used for growing cannabis. Shares take a hit.

CannTrust Falls as Health Canada Issues Non-Compliance Report

Aphria

The recent poor performance of marijuana stocks can be traced to one source.

Forget Short-Sellers! This Is the No.

Canopy Growth

Cronos Group

GW Pharmaceuticals

Scotts Miracle-Gro

Several economists and market researchers believe that the four  bills may pave the way for marijuana ETFs, which are likely to attract billions of dollars in investment.

5 Picks Ahead of Key Congressional Hearing on Marijuana Laws

BMO Capital Markets became the latest bank to downgrade the shares of Canadian cannabis company CannTrust Holdings Inc.

BMO downgrades CannTrust after Canadian government seizes its cannabis for unlicensed growing

Canadian medical marijuana producer CannTrust was slapped with a noncompliance report from Health Canada for growing cannabis in unlicensed rooms in its largest greenhouse facility and for providing inaccurate information to the regulator.

Noncompliance report puts CannTrust pot on hold

In recent CannTrust news, CTST stock is down more than 20% on Monday as regulators seized the company's cannabis. Here's what you should know.

CannTrust News: Why CTST Stock Is Plunging Today

Cannabis producer company CannTrust Holdings Inc (NYSE: CTST) said Monday that it accepts a Health Canada non-compliance finding; this "sharp turn of events" prompted Bank of America Merrill Lynch to double downgrade the stock.

Bank Of America Double Downgrades CannTrust After Health Canada Findings

Most marijuana stocks fell Monday after Canadian cannabis producer CannTrust said the government found it ran afoul of some regulations.
The post Marijuana Stocks Fall As Canadian Regulators Crack Down On CannTrust appeared first on Investor's Business Daily.

Marijuana Stocks Fall As Canadian Regulators Crack Down On CannTrust

"420 Investor" Alan Brochstein has a simple message to CannTrust Holdings Inc (NYSE: CTC) CEO Peter Aceto: apologize for violating Health Canada rules and resign.

'420 Investor' Brochstein To CannTrust CEO: Apologize And Resign

Canada-based producer of medical and recreational cannabis company CannTrust Holdings Inc (NYSE: CTST) responded to a Health Canada decision that one of its greenhouse facilities is non-compliant with regulations.

CannTrust Plummets Following Health Canada Compliance Issue, Potential Supply Shortage

The U.S.-listed shares of CannTrust Holdings Inc. CTST, +0.00% tumbled 11% toward a new low for the year after the Canada-based cannabis company said it greenhouse facility in Pelham, Ontario was deemed "non-compliant" by regulators.

CannTrust's stock tumbles after facility found non-compliant, cannabis inventory held

Aurora Cannabis

It was going to happen, and even though many of the top cannabis stocks are based in Canada and get coverage there, until recently, there has been little major Wall Street coverage in the United States.

Merrill Lynch Is Very High on 5 Top Buy-Rated Marijuana Stocks

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

A broad-based sell-off in marijuana stocks last quarter spared few cannabis investors.

These Pot Stocks Lost at Least 20% in the Second Quarter

MTech Acquisition

If you follow marijuana stocks, seek out the critical levels and price trends to understand how to place low-risk, high-return trades.

7 Marijuana Stocks With Critical Levels to Watch.

Citigroup initiated coverage of CannTrust Holdings Inc. CTST, +0.40% TRST, -0.46% with a high risk buy rating, citing growing revenue but less clarity on a path to profitability.

CannTrust initiated with high risk buy rating at Citigroup

ABIOMED

Cardinal Health

Find out why Cardinal Health, CannTrust Holdings, and Abiomed have our healthcare experts feeling giddy right now.

3 Top Healthcare Stocks to Buy

In the latest trading session, CannTrust Holdings Inc. (CTST) closed at $4.98, marking a +0.2% move from the previous day.

CannTrust Holdings Inc. (CTST) Gains But Lags Market: What You Should Know

JD.com

Vivint Solar

These could be among the fastest-growing shares over that time frame.

Three Stocks - Poised for Huge Growth Over the Next Decade

Perhaps unsurprisingly, derivative cannabis products won't launch on time.

Health Canada Just Failed the Marijuana Industry... Again

Trulieve Cannabis Corp.

Despite what you might think, bargains abound within the cannabis industry.

The Top Marijuana Stocks to Buy for the Second Half of 2019

Village Farms International

CBD-rich hemp could be a high-growth stepping stone into the U.S. for these half-dozen Canadian cannabis stocks.

Nearly Half of All Major Canadian Pot Growers Have Entered the U.S. Hemp Market

Canadian cannabis company CannTrust Holdings Inc (NYSE: CTST) announced an expansion Wednesday to the U.S.

BofA: CannTrust's Global Expansion 'Underappreciated'

Canadian marijuana producer CannTrust Holdings announced that it's entering the U.S. market by way of a joint venture to produce hemp for cannabidiol (CBD), and shares soared 8.9%.

CannTrust expands into the U.S.

Canadian pot producer CannTrust plans to enter the U.S. hemp-derived CBD market via a joint venture that will focus on production in California.

News for CannTrust Holdings Stock (CTST)